Journal of Diabetes Research / 2018 / Article / Tab 1

Review Article

Variables to Be Monitored via Biomedical Sensors for Complete Type 1 Diabetes Mellitus Management: An Extension of the “On-Board” Concept

Table 1

Current commercialized CGM sensor systems.

CompanyModelFeaturesMARD

AbbottTrend marks
Rate-of-change alerts
Alarms (hyper/hypo)
5-day lifetime
Calibration recommended up to 72 h14.5% [26]
Trend marks
No alerts or alarms
14-day lifetime
NFC communication with smartphone
Read approaching meter to sensor (NFC technology)
No calibration needed
11.4% [27]

DexcomTrend marks
Rate-of-change alerts
Alarms (hyper/hypo)
7-day lifetime
Remote monitoring
Calibration every 12 h
13% [28] (Original algorithm)
Trend marks
Rate-of-change alerts
Alarms (hyper/hypo)
7-day lifetime
Remote monitoring
Wireless communication with smartphone
Calibration every 12 h
9% [29]

MedtronicTrend marks
Rate-of-change alerts
Alarms (hyper/hypo)
6-day lifetime
Integration with Medtronic 530G insulin pumps
Calibration every 12 h
13.6% [30]
Trend arrows
Rate-of-change alerts
Alarms (hyper/hypo)
7-day lifetime
Integration with Medtronic 670G insulin pumps
Calibration every 12 h
9.1% [31]

SenseonicsTrend arrows
Rate-of-change alerts
Alarms (hyper/hypo)
90-day lifetime
Communication with smartphone
Sensor inserted under the skin
11.6% [32]

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.